Newly Approved Oral Medication Slows Rheumatoid Arthritis Joint Damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis patients who did not respond to methotrexate .
Join the discussion below, or Read more at MediLexicon.
Since: Jan 13
#1 Jan 25, 2013
This could be great information for arthritis people.Thanks for information.
#2 Apr 1, 2013
Wow this is amazing if it really slows down the effects of arthritis. I have read somewhere at depuypinnaclelawsuit. com that there may be some preoblems with hip replacements so this is a new alternative.
Add your comments below
|I'm a board certified Rheumatologist but curren... (Sep '14)||May 3||jaris280||3|
|Patients grapple with high cost of arthritis me...||Apr '15||bethwalker85||1|
|Baptism by Radon: Cure for Erectile Dysfunction... (Aug '12)||Mar '15||mbprabhu||14|
|'Nerve Hack' Offers Arthritis Sufferers Hope||Mar '15||mbprabhu||3|
|U-M study shows higher rates of lupus among Afr... (Oct '13)||Feb '15||Darren||8|
|Osteoporosis (Jun '12)||Jan '15||Cathy Smith||7|
|What is a urologist? What do urologists do?||Dec '14||pailrider||2|
Find what you want!
Search Rheumatology Forum Now
Copyright © 2015 Topix LLC